Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY, PARTNERS??? CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY, PARTNERS’ CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST - USD ($)
$ in Thousands
Total
Culture Kings
Common Stock
Common Stock
Culture Kings
Partnership Units
Additional Paid-In Capital
Additional Paid-In Capital
Culture Kings
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interest
Total Equity                    
Equity-based compensation $ 122         $ 122        
Cumulative translation adjustment (6,571)             $ (5,845)   $ (726)
Net income (loss) (64)               $ (62) (2)
Beginning balance (in shares) at Dec. 31, 2019         113,761,338          
Beginning balance at Dec. 31, 2019 112,041       $ 107,747 494   (4,731) (196) 8,727
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Equity-based compensation 122         122        
Cumulative translation adjustment (6,571)             (5,845)   (726)
Net income (64)               (62) (2)
Ending balance (in shares) at Mar. 31, 2020         113,761,338          
Ending balance at Mar. 31, 2020 105,528       $ 107,747 616   (10,576) (258) 7,999
Total Equity                    
Cumulative translation adjustment 2,129                  
Net income (loss) 9,508                  
Beginning balance (in shares) at Dec. 31, 2019         113,761,338          
Beginning balance at Dec. 31, 2019 112,041       $ 107,747 494   (4,731) (196) 8,727
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Cumulative translation adjustment 2,129                  
Net income 9,508                  
Ending balance (in shares) at Sep. 30, 2020         114,167,842          
Ending balance at Sep. 30, 2020 124,962       $ 108,197 1,328   (2,620) 9,010 9,047
Total Equity                    
Equity-based compensation 297         297        
Cumulative translation adjustment (389)             (285)   (104)
Net income (loss) 2,278               2,206 72
Beginning balance (in shares) at Mar. 31, 2020         113,761,338          
Beginning balance at Mar. 31, 2020 105,528       $ 107,747 616   (10,576) (258) 7,999
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Issuance of units (in shares)         406,504          
Issuance of units 450       $ 450          
Equity-based compensation 297         297        
Cumulative translation adjustment (389)             (285)   (104)
Net income 2,278               2,206 72
Ending balance (in shares) at Jun. 30, 2020         114,167,842          
Ending balance at Jun. 30, 2020 108,164       $ 108,197 913   (10,861) 1,948 7,967
Total Equity                    
Equity-based compensation 415         415        
Cumulative translation adjustment 9,089             8,241   848
Net income (loss) 7,294               7,062 232
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Equity-based compensation 415         415        
Cumulative translation adjustment 9,089             8,241   848
Net income 7,294               7,062 232
Ending balance (in shares) at Sep. 30, 2020         114,167,842          
Ending balance at Sep. 30, 2020 $ 124,962       $ 108,197 1,328   (2,620) 9,010 9,047
Beginning Balance (in shares) at Dec. 31, 2020 0   0   114,167,842 [1]          
Beginning Balance at Dec. 31, 2020 $ 138,884   $ 0   $ 108,197 [1] 727   5,839 14,138 9,983
Total Equity                    
Issuance of units (in shares)     0   25,746,282 [1]          
Issuance of units 82,669   $ 0   $ 82,669 [1]          
Equity-based compensation 523         523        
Cumulative translation adjustment (3,842)             (3,444)   (398)
Net income (loss) 1,790               1,472 318
Ending Balance (in shares) at Mar. 31, 2021     0   139,914,124 [1]          
Ending Balance at Mar. 31, 2021 220,024   $ 0   $ 190,866 [1] 1,250   2,395 15,610 9,903
Beginning Balance at Dec. 31, 2020 0                  
Redeemable Noncontrolling Interest                    
Noncontrolling interest from purchase of Culture Kings 142,717                  
Cumulative translation adjustment (1,575)                  
Ending Balance at Mar. 31, 2021 141,142                  
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Equity-based compensation $ 523         523        
Beginning Balance (in shares) at Dec. 31, 2020 0   0   114,167,842 [1]          
Beginning Balance at Dec. 31, 2020 $ 138,884   $ 0   $ 108,197 [1] 727   5,839 14,138 9,983
Total Equity                    
Cumulative translation adjustment (31,245)                  
Net income (loss) $ (6,114)                  
Ending Balance (in shares) at Sep. 30, 2021 126,590,142   126,590,142   0 [1]          
Ending Balance at Sep. 30, 2021 $ 408,909   $ 127   $ 0 [1] 415,341   (14,706) 8,147 0
Beginning Balance at Dec. 31, 2020 0                  
Ending Balance at Sep. 30, 2021 0                  
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Cumulative translation adjustment (31,245)                  
Net income (6,114)                  
Beginning Balance (in shares) at Mar. 31, 2021     0   139,914,124 [1]          
Beginning Balance at Mar. 31, 2021 220,024   $ 0   $ 190,866 [1] 1,250   2,395 15,610 9,903
Total Equity                    
Equity-based compensation 609         609        
Cumulative translation adjustment (3,846)             (3,709)   (137)
Net income (loss) 2,684               2,431 253
Ending Balance (in shares) at Jun. 30, 2021     0   139,914,124 [1]          
Ending Balance at Jun. 30, 2021 219,471   $ 0   $ 190,866 [1] 1,859   (1,314) 18,041 10,019
Beginning Balance at Mar. 31, 2021 141,142                  
Redeemable Noncontrolling Interest                    
Cumulative translation adjustment (1,835)                  
Net income (loss) (495)                  
Ending Balance at Jun. 30, 2021 138,812                  
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Equity-based compensation 609         609        
Issuance of units (in shares)     10,000,000              
Issuance of units 95,482   $ 10     95,472        
Equity-based compensation 5,582         5,582        
Cumulative translation adjustment (13,863)             (13,392)   (471)
Cumulative translation adjustment (20,146)                  
Net income (loss) (9,843)               (9,894) 51
Net income (loss) (10,093)                  
Purchase of Petal & Pup noncontrolling interest (20,198)         (10,599)       (9,599)
Purchase of Culture Kings noncontrolling interest (in shares)       21,809,804            
Purchase of Culture Kings noncontrolling interest   $ 132,278   $ 22     $ 132,256      
Reorganization transactions (in shares)     94,780,338   (139,914,124) [1]          
Reorganization transactions $ 0   $ 95   $ (190,866) [1] 190,771        
Ending Balance (in shares) at Sep. 30, 2021 126,590,142   126,590,142   0 [1]          
Ending Balance at Sep. 30, 2021 $ 408,909   $ 127   $ 0 [1] 415,341   $ (14,706) $ 8,147 $ 0
Redeemable Noncontrolling Interest                    
Cumulative translation adjustment (6,283)                  
Purchase of Culture Kings noncontrolling interest (132,278)                  
Net income (loss) (251)                  
Ending Balance at Sep. 30, 2021 0                  
Increase (Decrease) in Partners' Capital [Roll Forward]                    
Equity-based compensation 5,582         $ 5,582        
Cumulative translation adjustment (20,146)                  
Net income $ (10,093)                  
[1] Excelerate, L.P. was the predecessor entity to a.k.a. Brands Holding Corp. Refer to Note 1 for additional information.